EQUITY-BASED INCENTIVE PLANS - Nonvested Restricted Stock Activity (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
RSAs
Shares
Number of nonvested shares outstanding, beginning	406,001	517,569
Nonvested shares granted	0	296,000
Nonvested shares vested	(178,169)	(309,567)
Nonvested shares forfeited	(34,167)	(98,001)
Number of nonvested shares outstanding, ending	193,665	406,001	517,569
Unrecognized stock-based compensation expense	$ 392
Weighted Average Grant Date Fair Value
Weighted average exercise price outstanding, beginning (in usd per share)	$ 4.02	$ 4.74
Weighted average exercise price outstanding, nonvested options granted (in usd per share)	0	3.62
Weighted average exercise price outstanding, options vested (in usd per share)	4.10	4.57
Weighted average exercise price outstanding, options forfeited (in usd per share)	4.38	4.87
Weighted average exercise price outstanding, ending (in usd per share)	$ 3.87	$ 4.02	$ 4.74
Weighted average remaining vesting period	1 year 1 month 6 days
RSUs
Shares
Number of nonvested shares outstanding, beginning	450,000
Nonvested shares vested	(505,853)
Nonvested shares forfeited			(450,000)
Number of nonvested shares outstanding, ending	142,759	450,000
Unrecognized stock-based compensation expense	$ 4,095
Restricted Shares
Nonvested restricted stock outstanding, beginning balance (in shares)	842,302	1,014,166
Nonvested restricted stock granted (in shares)	1,116,875	709,804
Nonvested restricted stock vested (in shares)	(327,684)	(646,668)
Nonvested restricted stock forfeited (in shares)	(223,002)	(235,000)
Nonvested restricted stock outstanding, ending balance (in shares)	1,408,491	842,302	1,014,166
Weighted Average Grant Date Fair Value
Weighted average exercise price outstanding, beginning (in usd per share)	$ 4.42	$ 3.73
Weighted average exercise price outstanding, nonvested options granted (in usd per share)	4.34	3.73
Weighted average exercise price outstanding, options vested (in usd per share)	4.62	2.65
Weighted average exercise price outstanding, options forfeited (in usd per share)	4.38	4.21
Weighted average exercise price outstanding, ending (in usd per share)	$ 4.31	$ 4.42	$ 3.73
Weighted average remaining vesting period	2 years
Performance Shares
Shares
Unrecognized stock-based compensation expense	$ 0
Restricted Shares
Nonvested restricted stock outstanding, beginning balance (in shares)	0
Nonvested restricted stock granted (in shares)	1,981,464
Nonvested restricted stock vested (in shares)	0
Nonvested restricted stock forfeited (in shares)	0
Nonvested restricted stock outstanding, ending balance (in shares)	1,981,464	0
Weighted Average Grant Date Fair Value
Weighted average exercise price outstanding, beginning (in usd per share)	$ 0
Weighted average exercise price outstanding, nonvested options granted (in usd per share)	4.61
Weighted average exercise price outstanding, options vested (in usd per share)	0
Weighted average exercise price outstanding, options forfeited (in usd per share)	0
Weighted average exercise price outstanding, ending (in usd per share)	$ 4.61	$ 0
Weighted average remaining vesting period	0 days